Veilig stoppen met nilotinib bij CML-CP

Delen via:

Log hier in om volledige toegang te krijgen.

Login of Account maken

 



Bronnen:

  1. Hochhaus A, Masszi T, Giles FJ, et al. Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study. Leukemia. 2017;31:1525-31.,Baccarani M, Deininger MW, Rosti G, et al. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood. 2013;122:872-84,National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Chronic Myeloid Leukemia, v1.2017. Beschikbaar op: https://www.nccn.org/professionals/physician_gls/pdf/cml.pdf